# BIOHAVEN PHARMACTL HLDG CO L (BHVNXXXX)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/BHVNXXXX/

- Reporting holders: 1
- Reported value: $35.0M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Knoll Capital Management, LLC](https://holderbook.com/funds/1325083-knoll-capital-management-llc/) | $35.0M | 4,681,122 | 8.9% | 31 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 1 | $35.0M |
| Q1 2026 | 1 | $19.7M |
| Q4 2025 | 2 | $27.0M |
| Q3 2025 | 2 | $13.5M |
| Q2 2025 | 2 | $12.7M |
| Q1 2025 | 2 | $20.0M |
| Q4 2024 | 2 | $29.0M |
| Q3 2024 | 3 | $36.6M |
| Q2 2024 | 3 | $25.2M |
| Q1 2024 | 2 | $27.6M |
| Q4 2023 | 2 | $21.6M |
| Q3 2023 | 1 | $12.8M |